Literature DB >> 17724680

Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.

Mariëlle M M T J Ouwens1, Rosella R P M G Hermens, René A R Termeer, Saskia Y Vonk-Okhuijsen, Vivianne C G Tjan-Heijnen, Ad F T M Verhagen, Marlies M E J L Hulscher, Henri A M Marres, Hub C H Wollersheim, Richard P T M Grol.   

Abstract

BACKGROUND: In the current study, the authors focused on determinants influencing the quality of care and variations in the actual quality of integrated care for patients with nonsmall cell lung cancer (NSCLC) to estimate whether there is room for improvement.
METHODS: The authors tested the quality of integrated care for 276 NSCLC patients with 14 quality indicators of professional (4 indicators), organizational (3 indicators), and patient-oriented quality (7 indicators). Patient characteristics and actual care data were derived from medical record data, patient-oriented care was derived from patient questionnaires, and professional and hospital characteristics were derived from questionnaires for professionals. The performance measure was the proportion of patients to whom the indicator applied who had positive scores on the indicator. Multilevel logistic regression analysis determined the influence of patient, professional, and hospital characteristics on care.
RESULTS: With regard to professional quality, the proportions of patients who underwent fluorodeoxyglucose-positron emission tomography or cervical mediastinoscopy according to the guideline criteria were 88% and 84%, respectively. Only 50% of the biopsies were adequately obtained during mediastinoscopy, and in 3% of the patients with clinical stage III disease (based on the TNM classification) there was a search for brain metastases before the initiation of combination therapy. With regard to organizational quality, the diagnostic route of 79% of the patients was completed within 21 days; 51% of patients began therapy within 35 days and 57% were discussed during multidisciplinary consultation. All but 1 patient-oriented quality indicator scored </=58%. Hospitals varied by >/=20% with regard to 11 of the 14 indicators. The patient-related determinants "stage of disease," "age," and "comorbidity" were found to influence the indicator scores the most.
CONCLUSIONS: The quality of integrated care (especially patient-oriented care) for NSCLC patients needs improvement. Patient characteristics appear to influence performance more than professional or hospital characteristics.

Entities:  

Mesh:

Year:  2007        PMID: 17724680     DOI: 10.1002/cncr.22986

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in Florida.

Authors:  Tawee Tanvetyanon; Michelle Corman; Ji-Hyun Lee; William J Fulp; Fred Schreiber; Richard H Brown; Richard M Levine; Thomas H Cartwright; Guillermo Abesada-Terk; George P Kim; Carlos Alemany; Douglas Faig; Philip V Sharp; Merry-Jennifer Markham; Gerold Bepler; Erin Siegel; David Shibata; Mokenge Malafa; Paul B Jacobsen
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

2.  Quality indicators for the evaluation of patients with lung cancer.

Authors:  Peter J Mazzone; Anil Vachani; Andrew Chang; Frank Detterbeck; David Cooke; John Howington; Amos Dodi; Douglas Arenberg
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

3.  The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.

Authors:  Rob G Stirling; S M Evans; P McLaughlin; M Senthuren; J Millar; J Gooi; L Irving; P Mitchell; A Haydon; J Ruben; M Conron; T Leong; N Watkins; J J McNeil
Journal:  Lung       Date:  2014-06-08       Impact factor: 2.584

4.  How Much Delay Matters? How Time to Treatment Impacts Overall Survival in Early Stage Lung Cancer.

Authors:  Andrew Tang; Usman Ahmad; Siva Raja; Alejandro C Bribriesco; Monisha Sudarshan; Jesse Rappaport; Alok Khorana; Eugene H Blackstone; Sudish C Murthy; Daniel Raymond
Journal:  Ann Surg       Date:  2021-11-18       Impact factor: 13.787

5.  Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Authors:  Benjamin P Levy; Marc D Chioda; Dana Herndon; John W Longshore; Mohamed Mohamed; Sai-Hong Ignatius Ou; Craig Reynolds; Jaspal Singh; Ignacio I Wistuba; Paul A Bunn; Fred R Hirsch
Journal:  Oncologist       Date:  2015-09-01

6.  Improving long-term care provision: towards demand-based care by means of modularity.

Authors:  Carolien de Blok; Katrien Luijkx; Bert Meijboom; Jos Schols
Journal:  BMC Health Serv Res       Date:  2010-09-21       Impact factor: 2.655

7.  How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.

Authors:  Giulia Pasello; Jessica Menis; Sara Pilotto; Stefano Frega; Lorenzo Belluomini; Federica Pezzuto; Anna Caliò; Matteo Sepulcri; Nunzia Luna Valentina Cernusco; Marco Schiavon; Maurizio Valentino Infante; Marco Damin; Claudio Micheletto; Paola Del Bianco; Riccardo Giovannetti; Laura Bonanno; Umberto Fantoni; Valentina Guarneri; Fiorella Calabrese; Federico Rea; Michele Milella; PierFranco Conte
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

8.  Development and testing of indicators to measure coordination of clinical information and management across levels of care.

Authors:  Marta-Beatriz Aller; Ingrid Vargas; Jordi Coderch; Sebastià Calero; Francesc Cots; Mercè Abizanda; Joan Farré; Josep Ramon Llopart; Lluís Colomés; María Luisa Vázquez
Journal:  BMC Health Serv Res       Date:  2015-08-13       Impact factor: 2.655

9.  Variation in guideline adherence in non-Hodgkin's lymphoma care: impact of patient and hospital characteristics.

Authors:  Jozette J C Stienen; Rosella P M G Hermens; Lianne Wennekes; Saskia A M van de Schans; Richard W M van der Maazen; Helena M Dekker; Janine Liefers; Johan H J M van Krieken; Nicole M A Blijlevens; Petronella B Ottevanger
Journal:  BMC Cancer       Date:  2015-08-08       Impact factor: 4.430

10.  Appropriate antibiotic use for patients with complicated urinary tract infections in 38 Dutch Hospital Departments: a retrospective study of variation and determinants.

Authors:  V Spoorenberg; S E Geerlings; R B Geskus; T M de Reijke; J M Prins; M E J L Hulscher
Journal:  BMC Infect Dis       Date:  2015-11-09       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.